BBLS, a life sciences accelerator, identifies and manages investments on behalf of the Bosarge family office and other investors to expedite the translation of novel technologies to the clinic. Our goal is to enhance patient outcomes through the accelerated generation and development of novel therapies, while at the same time hastening revenue generation. We focus on approaches that target regenerative medicine, anti-aging, immune cell therapy, and diabetes treatments. BBLS works to extend healthy living so people can age gracefully and live well longer. With collaboration-focused leadership, access to smart capital and expert knowledge sharing, BBLS transforms science and medical innovations into breakthrough therapies.
BBLS stems from the vision of Dr. Ed Bosarge who has had multiple successes across a variety of industries with his multi-disciplinary approach grounded in science and mathematics. Dr. Bosarge envisioned a team with clinical, science, management, marketing, technology, financial and legal expertise. To execute on this vision, BBLS is assembling a world-class team capable of evaluating, managing and commercializing life science technologies. BBLS is led by Chief Executive Officer, Marc S. Penn, MD, PhD, FACC, a world-renowned cardiologist, stem-cell and regenerative medicine expert and serial inventor and entrepreneur.
Ultimately, we will increase the value, achieve sustained growth and optimize return for the BBLS portfolio of companies while delivering best in class therapeutics for healthier living and improved patient outcomes. That’s the BBLS promise.